95 related articles for article (PubMed ID: 27784353)
21. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
22. [Suppressive effect of artesunate on K562 cell growth and its influence on VEGF expression].
Lai JP; Huang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):777-80. PubMed ID: 18718059
[TBL] [Abstract][Full Text] [Related]
23. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.
Ebos JM; Tran J; Master Z; Dumont D; Melo JV; Buchdunger E; Kerbel RS
Mol Cancer Res; 2002 Dec; 1(2):89-95. PubMed ID: 12496355
[TBL] [Abstract][Full Text] [Related]
24. [Effect of Arsenic Trioxide on K562 Cell Proliferation and Its Mechanism].
Wang Y; Yang J; Li J; Wang RC; Yuan J; Li Y; Wang SY; Wang C; Hao HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):90-93. PubMed ID: 28245381
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
26. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
27. [SHP-1 gene in the disease progression of chronic myeloid leukemia].
Li Y; Wang X; Yang L; Pan Y; Shang Y; Luo J
Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1074-8. PubMed ID: 25543700
[TBL] [Abstract][Full Text] [Related]
28. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
[TBL] [Abstract][Full Text] [Related]
29. VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia.
Luo X; Feng M; Zhu X; Li Y; Fei J; Zhang Y
Hematology; 2013 Nov; 18(6):334-40. PubMed ID: 24129092
[TBL] [Abstract][Full Text] [Related]
30. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
[TBL] [Abstract][Full Text] [Related]
31. [Inhibition of leukemic cell proliferation by human soluble VEGF-R1].
Zhu J; Song YQ; Li W; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):168-74. PubMed ID: 17490547
[TBL] [Abstract][Full Text] [Related]
32. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
33. [Effect of siRNA targeting VEGF on cell apoptosis and the expression of survivin in K562 cells.].
Li FF; Zheng GH; Xu YH; Luo Q
Zhonghua Xue Ye Xue Za Zhi; 2009 Dec; 30(12):825-8. PubMed ID: 20193604
[TBL] [Abstract][Full Text] [Related]
34. [Anti-apoptosis effect of VEGF on the human chronic myelocytic leukemia cell line K562].
Zhu YY; Ye DF; Lin JA; Weng SM; Liang XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):778-82. PubMed ID: 16277841
[TBL] [Abstract][Full Text] [Related]
35. [Apoptosis-inducing effect of Scutellaria barbata extract on human lung cancer SPC-A-1 cells and the expression of apoptosis associated genes].
Wei PY; Pu HQ; Wei X; Li CG; Nong S
Zhong Yao Cai; 2007 Oct; 30(10):1270-3. PubMed ID: 18300501
[TBL] [Abstract][Full Text] [Related]
36. [Effect of Nrf2 and TrxR on proliferation of chronic myeloid leukemia cell and its mechanism].
Pan F; Xu LR; Wang HW; Zhu MX; Liu Y; Tan YH; Chen XH; Ren FG
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):527-31. PubMed ID: 23827113
[TBL] [Abstract][Full Text] [Related]
37. [Effect of A Novel Emodin Derivative on Chronic Myelogenous Leukemia K562 Cells and Imatinib-resistant K562/G01 Cells].
Li BJ; Liu TB; Wang WF; Lin MH; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):1-7. PubMed ID: 26913384
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
[TBL] [Abstract][Full Text] [Related]
39. [Screening of anti-tumor parts from the seeds of Livistona chinensis and its anti-angiogenesis effect].
Wang H; Li A; Dong XP; Xu XY
Zhong Yao Cai; 2008 May; 31(5):718-22. PubMed ID: 18826151
[TBL] [Abstract][Full Text] [Related]
40. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
Dilloo D; Hanenberg H; Lion T; Burdach S
Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
